Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.350
+0.090 (7.14%)
At close: Apr 16, 2026, 4:00 PM EDT
1.360
+0.010 (0.73%)
After-hours: Apr 16, 2026, 7:49 PM EDT
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $5.43 million as of April 16, 2026. Its market cap has decreased by -7.42% in one year.
Market Cap
5.43M
Enterprise Value
-2.09M
1-Year Change
-7.42%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $5.43M, a decrease of -90.55%. That is a compound annual growth rate of -39.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 5.07M | -17.88% |
| Dec 31, 2025 | 6.17M | 124.01% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
| Aug 13, 2021 | 57.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio Green Med Solution | 5.74M |
| Mustang Bio | 5.68M |
| Cardio Diagnostics Holdings | 5.68M |
| Jaguar Health | 5.29M |
| Akari Therapeutics, | 5.24M |
| Indaptus Therapeutics | 5.22M |
| Ensysce Biosciences | 4.82M |
| AIM ImmunoTech | 4.71M |